Your Cart

Call us: +1 (870) 533-5581

Free shipping on all orders over $100 (US) and $300 (International)


CJC-1295 without DAC 2 mg



504 in stock


6 in stock

This item is selling fast!

Free shipping on all orders over $100 (US) and $300 (International)

Guaranteed Safe Checkout:

“SwissChems Payment Methods


  • Chemical Formula: C152H252N44O42
  • Molecular Mass: 3367.9
  • Synonyms: GHRH (1-29)-NH2
  • Molar Mass: 3367.9
  • CAS Number: 446262-90-4
  • PubChem: 91976842
  • Total Amount of the Active Ingredient: 2mg
  • Shelf Life: 36 months



  • CJC-1295 is a synthetic peptide that belongs to a class of compounds called growth hormone-releasing hormones (GHRHs). It binds to the GHRH receptor in the pituitary gland, which then triggers the release of growth hormones into the bloodstream.

It provides sustained stimulation of GH release over a longer period of time due to a longer half-life than other GHRHs. It has been investigated for its potential therapeutic use in conditions associated with GH deficiency, such as growth hormone deficiency, aging, and muscle wasting.

Some studies have shown that CJC-1295 can increase muscle mass and improve muscle strength, decrease body fat, and improve skin elasticity in older adults, including patients with cancer, COPD, and HIV/AIDS. Several clinical studies have also shown that CJC-1295 can increase levels of insulin-like growth factor-1 (IGF-1) and improve growth in children with growth hormone deficiency.

CJC -1295 without DAC (Drug Affinity Complex) is a shorter-acting form of the peptide that does not bind to serum albumin and is rapidly cleared.

Product Quality

All of our products are lab tested and the results are occasionally published on the website.

You can have the product you bought from us tested at any HPLC-licensed testing facility and if the results are negative, we will refund the following:

  • Cost of HPLC test
  • Total amount of the order + shipping fee

Independent Test Results

All of our products are lab tested and the results are periodically published on the website.


Peer-Reviewed Studies 

Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006)

The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.

Henninge, J., Pepaj, M., Hullstein, I., & Hemmersbach, P. (2010)

Drug testing and analysis, 2(11‐12), 647-650.